Ad is loading...
BEAM
Price
$24.05
Change
-$2.26 (-8.59%)
Updated
Nov 15 closing price
107 days until earnings call
BPMC
Price
$88.69
Change
-$6.96 (-7.28%)
Updated
Nov 15 closing price
88 days until earnings call
Ad is loading...

BEAM vs BPMC

Header iconBEAM vs BPMC Comparison
Open Charts BEAM vs BPMCBanner chart's image
Beam Therapeutics
Price$24.05
Change-$2.26 (-8.59%)
Volume$2.26M
CapitalizationN/A
Blueprint Medicines
Price$88.69
Change-$6.96 (-7.28%)
Volume$1M
CapitalizationN/A
BEAM vs BPMC Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BPMC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BEAM vs. BPMC commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongSell and BPMC is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BEAM: $24.05 vs. BPMC: $88.69)
Brand notoriety: BEAM and BPMC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 218% vs. BPMC: 155%
Market capitalization -- BEAM: $1.99B vs. BPMC: $5.63B
BEAM [@Biotechnology] is valued at $1.99B. BPMC’s [@Biotechnology] market capitalization is $5.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileBPMC’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • BPMC’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than BPMC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while BPMC’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • BPMC’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than BPMC.

Price Growth

BEAM (@Biotechnology) experienced а -11.12% price change this week, while BPMC (@Biotechnology) price change was -12.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

BPMC is expected to report earnings on Feb 13, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($5.63B) has a higher market cap than BEAM($1.99B). BPMC YTD gains are higher at: -3.849 vs. BEAM (-11.646). BPMC has higher annual earnings (EBITDA): -75.58M vs. BEAM (-162.88M). BEAM has more cash in the bank: 1.01B vs. BPMC (734M). BEAM has less debt than BPMC: BEAM (165M) vs BPMC (471M). BPMC has higher revenues than BEAM: BPMC (434M) vs BEAM (353M).
BEAMBPMCBEAM / BPMC
Capitalization1.99B5.63B35%
EBITDA-162.88M-75.58M216%
Gain YTD-11.646-3.849303%
P/E RatioN/AN/A-
Revenue353M434M81%
Total Cash1.01B734M137%
Total Debt165M471M35%
FUNDAMENTALS RATINGS
BPMC: Fundamental Ratings
BPMC
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
83
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMBPMC
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 11 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
76%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BPMC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FLUD24.890.05
+0.21%
Franklin Ultra Short Bond ETF
PZA23.870.02
+0.08%
Invesco National AMT-Free Muni Bd ETF
IBMO25.520.02
+0.08%
iShares iBonds Dec 2026 Term Muni Bd ETF
OVT22.19-0.07
-0.32%
Overlay Shares Short Term Bond ETF
SHDG29.31-0.29
-0.99%
Soundwatch Hedged Equity ETF

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-8.59%
CRSP - BEAM
74%
Closely correlated
+0.85%
NTLA - BEAM
69%
Closely correlated
-7.61%
DNLI - BEAM
65%
Loosely correlated
-11.95%
EDIT - BEAM
64%
Loosely correlated
-3.97%
RXRX - BEAM
62%
Loosely correlated
-10.64%
More

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
-7.28%
BEAM - BPMC
46%
Loosely correlated
-8.59%
BBIO - BPMC
45%
Loosely correlated
-1.62%
DNLI - BPMC
45%
Loosely correlated
-11.95%
SNDX - BPMC
44%
Loosely correlated
-5.72%
KRYS - BPMC
44%
Loosely correlated
-3.75%
More